EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2019 Update

Summary

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. EyePoints iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EyePoint Pharmaceuticals Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
EyePoint Pharmaceuticals Inc Company Overview
EyePoint Pharmaceuticals Inc Company Snapshot
EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
EyePoint Pharmaceuticals Inc Pipeline Analysis Overview
EyePoint Pharmaceuticals Inc - Key Facts
EyePoint Pharmaceuticals Inc - Major Products and Services
EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage
EyePoint Pharmaceuticals Inc Pipeline Products Overview
Durasert - Front Of Eye Disease
Durasert - Front Of Eye Disease Product Overview
Durasert - Knee Osteoarthritis
Durasert - Knee Osteoarthritis Product Overview
Durasert Latanoprost Implant
Durasert Latanoprost Implant Product Overview
DURASERT With TKI - Wet AMD
DURASERT With TKI - Wet AMD Product Overview
Tethadur System
Tethadur System Product Overview
YUTIQ - Shorter Duration
YUTIQ - Shorter Duration Product Overview
EyePoint Pharmaceuticals Inc - Key Competitors
EyePoint Pharmaceuticals Inc - Key Employees
EyePoint Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
EyePoint Pharmaceuticals Inc, Recent Developments
Aug 07, 2019: EyePoint Pharmaceuticals reports second quarter 2019 financial results and highlights recent company progress
Jul 15, 2019: EyePoint Pharmaceuticals appoints Wendy DiCicco, CPA, to board of directors
Jun 10, 2019: EyePoint Pharmaceuticals strengthens executive leadership team with key hires
May 01, 2019: EyePoint Pharmaceuticals presents positive YUTIQ 36-month follow-up phase 3 data at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Apr 16, 2019: EyePoint Pharmaceuticals to present at upcoming medical Conferences
Mar 14, 2019: Eyepoint Pharmaceuticals reports fiscal period ended december 31, 2018 financial results and highlights recent clinical and operational developments
Feb 13, 2019: EyePoint Pharmaceuticals secures up to $60 million debt facility
Feb 04, 2019: EyePoint Pharmaceuticals announces U.S. commercial launch of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg
Jan 28, 2019: EyePoint Pharmaceuticals names David Guyer, M.D., to Board of Directors
Nov 27, 2018: EyePoint Pharmaceuticals names Ron Honig, Esq., as SVP, general counsel & company secretary
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type
EyePoint Pharmaceuticals Inc Pipeline Products by Indication
EyePoint Pharmaceuticals Inc, Key Facts
EyePoint Pharmaceuticals Inc, Major Products and Services
EyePoint Pharmaceuticals Inc Number of Pipeline Products by Development Stage
EyePoint Pharmaceuticals Inc Pipeline Products Summary by Development Stage
Durasert - Front Of Eye Disease - Product Status
Durasert - Front Of Eye Disease - Product Description
Durasert - Knee Osteoarthritis - Product Status
Durasert - Knee Osteoarthritis - Product Description
Durasert Latanoprost Implant - Product Status
Durasert Latanoprost Implant - Product Description
DURASERT With TKI - Wet AMD - Product Status
DURASERT With TKI - Wet AMD - Product Description
Tethadur System - Product Status
Tethadur System - Product Description
YUTIQ - Shorter Duration - Product Status
YUTIQ - Shorter Duration - Product Description
EyePoint Pharmaceuticals Inc, Key Employees
EyePoint Pharmaceuticals Inc, Subsidiaries
Glossary

List Of Figures

List of Figures
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type
EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage

EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2019 Update

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 750 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 250 View Report

RespireRx Pharmaceuticals Inc (RSPI) - Strategic SWOT Analysis Review

RespireRx Pharmaceuticals Inc (RSPI) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available